Medicure Stock Buy Hold or Sell Recommendation
| MPH Stock | CAD 0.90 0.02 2.27% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Medicure is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Medicure given historical horizon and risk tolerance towards Medicure. When Macroaxis issues a 'buy' or 'sell' recommendation for Medicure, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Medicure Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Medicure and provide practical buy, sell, or hold advice based on investors' constraints. Medicure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Medicure |
Execute Medicure Buy or Sell Advice
The Medicure recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Medicure. Macroaxis does not own or have any residual interests in Medicure or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Medicure's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Extremely Dangerous | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Medicure Trading Alerts and Improvement Suggestions
| Medicure generated a negative expected return over the last 90 days | |
| Medicure has some characteristics of a very speculative penny stock | |
| Medicure has high historical volatility and very poor performance | |
| The company reported the revenue of 21.69 M. Net Loss for the year was (922 K) with profit before overhead, payroll, taxes, and interest of 12.71 M. | |
| About 27.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: MEDICURE TO PRESENT FINANCIAL RESULTS ON NOVEMBER 26, 2024 CALL at 830 AM ET FOR QUARTER ENDED SEPTEMBER 30, 2024 AND ANNOUNCES RESIGNATION OF BOARD MEMBER Form 6 K - Marketscreener.com |
Medicure Returns Distribution Density
The distribution of Medicure's historical returns is an attempt to chart the uncertainty of Medicure's future price movements. The chart of the probability distribution of Medicure daily returns describes the distribution of returns around its average expected value. We use Medicure price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Medicure returns is essential to provide solid investment advice for Medicure.
| Mean Return | -0.1 | Value At Risk | -8.33 | Potential Upside | 2.00 | Standard Deviation | 3.95 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Medicure historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Medicure Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (11.2M) | (10.2M) | 978K | 1.2M | 1.5M | 1.6M | |
| Free Cash Flow | (28.5M) | (2.2M) | 3.2M | 1.5M | 1.8M | 1.9M | |
| Depreciation | 1.9M | 2.8M | 3.1M | 2.1M | 2.2M | 1.6M | |
| Capital Expenditures | 13.8M | 2K | 818K | 310K | 270K | 256.5K | |
| Net Income | (19.8M) | (6.8M) | (727K) | 1.4M | (922K) | (968.1K) | |
| End Period Cash Flow | 13.0M | 2.7M | 3.7M | 4.9M | 6.4M | 6.8M | |
| Change To Inventory | (4.1M) | 723K | 471K | 166K | (31K) | (32.6K) | |
| Other Non Cash Items | 11.1M | (1.1M) | (20K) | (1.3M) | 51K | 53.6K | |
| Change To Netincome | (6.2M) | 11.7M | (873K) | 83K | 95.5K | 100.2K | |
| Investments | 41.4M | (7.2M) | (2.7M) | (310K) | (270K) | (283.5K) |
Medicure Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Medicure or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Medicure's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Medicure stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.2 | |
β | Beta against Dow Jones | 0.73 | |
σ | Overall volatility | 4.05 | |
Ir | Information ratio | -0.06 |
Medicure Volatility Alert
Medicure exhibits very low volatility with skewness of 2.4 and kurtosis of 18.66. Medicure is a potential penny stock. Although Medicure may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Medicure. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Medicure instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Medicure Fundamentals Vs Peers
Comparing Medicure's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Medicure's direct or indirect competition across all of the common fundamentals between Medicure and the related equities. This way, we can detect undervalued stocks with similar characteristics as Medicure or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Medicure's fundamental indicators could also be used in its relative valuation, which is a method of valuing Medicure by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Medicure to competition |
| Fundamentals | Medicure | Peer Average |
| Return On Equity | -0.13 | -0.31 |
| Return On Asset | -0.0563 | -0.14 |
| Profit Margin | (0.13) % | (1.27) % |
| Operating Margin | (0.22) % | (5.51) % |
| Current Valuation | 3.94 M | 16.62 B |
| Shares Outstanding | 10.44 M | 571.82 M |
| Shares Owned By Insiders | 26.67 % | 10.09 % |
| Shares Owned By Institutions | 23.09 % | 39.21 % |
| Number Of Shares Shorted | 2.69 K | 4.71 M |
| Price To Earning | 22.88 X | 28.72 X |
| Price To Book | 0.48 X | 9.51 X |
| Price To Sales | 0.45 X | 11.42 X |
| Revenue | 21.69 M | 9.43 B |
| Gross Profit | 12.71 M | 27.38 B |
| EBITDA | 1.32 M | 3.9 B |
| Net Income | (922 K) | 570.98 M |
| Cash And Equivalents | 45.7 M | 2.7 B |
| Cash Per Share | 3.07 X | 5.01 X |
| Total Debt | 544 K | 5.32 B |
| Debt To Equity | 0.70 % | 48.70 % |
| Current Ratio | 4.71 X | 2.16 X |
| Book Value Per Share | 1.87 X | 1.93 K |
| Cash Flow From Operations | 2.08 M | 971.22 M |
| Short Ratio | 1.52 X | 4.00 X |
| Earnings Per Share | (0.25) X | 3.12 X |
| Target Price | 2.8 | |
| Beta | 0.87 | -0.15 |
| Market Capitalization | 9.39 M | 19.03 B |
| Total Asset | 28.06 M | 29.47 B |
| Retained Earnings | (65.85 M) | 9.33 B |
| Working Capital | 7.27 M | 1.48 B |
| Net Asset | 28.06 M |
Medicure Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Medicure . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.02 | |||
| Day Median Price | 0.9 | |||
| Day Typical Price | 0.9 | |||
| Price Action Indicator | 0.01 | |||
| Period Momentum Indicator | 0.02 | |||
| Relative Strength Index | 61.79 |
About Medicure Buy or Sell Advice
When is the right time to buy or sell Medicure? Buying financial instruments such as Medicure Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Medicure in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Soft Drinks Thematic Idea Now
Soft Drinks
Entities manufacturing and distributing non alcoholic beverages across different markets. The Soft Drinks theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Soft Drinks Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Medicure Stock Analysis
When running Medicure's price analysis, check to measure Medicure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicure is operating at the current time. Most of Medicure's value examination focuses on studying past and present price action to predict the probability of Medicure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicure's price. Additionally, you may evaluate how the addition of Medicure to your portfolios can decrease your overall portfolio volatility.